The Pharmaceutical Market: Oman - Market Key Trends, Size, Growth, Shares And Forecast Research Report

The Pharmaceutical Market: Oman Size and Share Published in 2014-12-23 Available for US$ 1295 at Researchmoz.us"

Description

Oman Pharmaceuticals & Healthcare Report

Oman's commendable public healthcare system and high-class tertiary and quaternary care hospitals will increase the uptake of medical tourism by GCC citizens. The Omani pharmaceutical market will continue to remain heavily reliant on imports due to the costly need to source raw ingredients for local manufacturing and lack of R&D backing. However, despite t he strict drug pricing system, we are likely to see more multinational companies penetrating the market and expanding volume sales, by addressing the increasing burden of non-communicable diseases in the country.

Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=240620

Headline Expenditure Projections

Pharmaceuticals: OMR151mn (US$391mn) in 2011 to OMR166mn in 2012; +9.9% in local currency terms and +11.3% in US dollar terms. Forecastrevised upwards due tomodifications to historical figures.

Healthcare: OMR742mn (US$1.93bn) in 2011 to OMR839mn (US$2.21bn) in 2012; +13.1% in local currency terms and +14.6% in US dollar terms. Forecastrevised upwards due tomodifications to historical figures.

Medicaldevices: OMR40mn (US$105mn) in 2011 to OMR44mn (US$116mn) in 2012; +9.5% in local currency terms and +10.9% in US dollar terms. Forecastrevised upwards due tomodifications to historical figures.

Risk/RewardRating

Risk-Reward Rating scores represent a country's pharmaceutical market attractiveness for investment, which includes weightings of risk and rewards analysis of the wider macroeconomic environment. Oman's consistent score of 50.2 out of 100 over the past three quarters places it above the MEA regional average of 44.2, indicating a favourable and stable environment for multinational investment. Oman also currently maintains its position as ninth out of 30 countries in the MEA matrix.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=240620

Table of Content

BMI Industry View7

SWOT10

Political12

Economic13

Business Environment14

Industry Forecast15

Pharmaceutical Market Forecast15

Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2010-2018)16

Healthcare Market Forecast17

Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018)18

Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018)18

Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018)19

Prescription Drug Market Forecast20

Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2010-2018)21

Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/